Who said what in PhRMA's $80B deal?

PhRMA may be tired of talking about its $80 billion deal for healthcare reform, but if you're not tired of reading about it, check out Marc Ambinder's behind-the-scenes look at negotiations between the pharma lobby, Congress and the White House. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.